Bird Flu > Bird Flu News > Flu Vaccine Plan in U.S. May Shortchange Nations, Lancet Says (Bloomberg)

Flu Vaccine Plan in U.S. May Shortchange Nations, Lancet Says (Bloomberg)
The ingredients, called adjuvants, have never been approved for flu vaccines in the U.S. and are controversial because some studies show they cause immune disorders in mice.